Logo
Logo
  • Stories
  • Voices
  • Podcasts
  • Events
  • Search
  • Log In
  • Subscribe
  • Stories
  • Voices
  • Podcasts
  • Events

Follow Us

  • Search
  • Log In
  • Subscribe

Full coverage: Malin Corporation

Inside the Malin boardroom: Share wars, buybacks, and dividends

Following the lucrative sales of Kymab and Altan, Malin's founders make contested claims that the operating activities of the plc will virtually cease as the life sciences investment firm steadies its focus on returning capital to its shareholders.

Francesca Comyn
4th Nov, 2021 - 9 min read
Logo
  • About
  • Contact
  • Terms and Conditions
  • Privacy

© 2023 Currency Media Limited

Sign In

Forgot your password?
Logo

Not a subscriber yet?

Create an account